chr12-64017011-C-T
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2
The NM_020762.4(SRGAP1):c.488C>T(p.Thr163Met) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000793 in 1,512,358 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020762.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- thyroid cancer, nonmedullary, 2Inheritance: AD Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152114Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000831 AC: 2AN: 240762 AF XY: 0.0000154 show subpopulations
GnomAD4 exome AF: 0.00000735 AC: 10AN: 1360244Hom.: 0 Cov.: 21 AF XY: 0.0000118 AC XY: 8AN XY: 680318 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74310 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.488C>T (p.T163M) alteration is located in exon 4 (coding exon 4) of the SRGAP1 gene. This alteration results from a C to T substitution at nucleotide position 488, causing the threonine (T) at amino acid position 163 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at